Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
Evidence-based · Educational only
36+ Peptides indexed
Free research library
Free newsletter — subscribe below
★ = FDA-approved medical indication
Not medical advice — always consult a clinician
All peptides

SS-31

Also known as: Elamipretide
Research / Investigational

Elamipretide (SS-31) is a mitochondria-targeted tetrapeptide studied for mitochondrial myopathies and heart failure.

Buy SS-31 on American Peptides

Affiliate link — we may earn a commission at no extra cost to you.

Overview

Elamipretide (SS-31) is a mitochondria-targeted tetrapeptide studied for mitochondrial myopathies and heart failure.

FDA Approval Status

Not approved by the FDA. Investigational or intended for research purposes only.

Mechanism of Action

Binds cardiolipin on inner mitochondrial membrane, stabilizing cristae and improving ATP production.

Current Research

Ongoing clinical trials.
Research strength: Moderate

Potential Medical Uses

  • Investigational only

Potential Benefits

  • Preclinical mitochondrial function improvements

Known Side Effects

  • Injection-site reactions
  • GI symptoms

Contraindications

  • Hypersensitivity

Drug Interactions

  • Unknown

Administration Methods

  • Subcutaneous injection (clinical trials)

Half-life

~2.5 hours

Reconstitution

Trial-supplied formulations.

Storage & Handling

Per trial protocol.

References & Sources

Frequently Asked Questions

Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.